FDA approves new flu vaccine

Share this content:

The U.S. Food and Drug Administration approved a new flu vaccine from GlaxoSmithKline called FLUARIX.

Domestic   distribution   of   the   new   vaccine   is   scheduled   to   take   place   during the upcoming flu season. Already distributed in 79 countries outside the U.S.,  it will be available exclusively in Tip-Lok® syringes.  
 
The announcement comes on the heels of a new regulation that requires long-term care facilities to offer annual flu shots.

"The shortage of flu vaccine last year was a reminder of the importance of vaccines in healthcare," said Jean-Pierre Garnier, CEO of GlaxoSmithKline.